CYTC is the only stock I hold for more than 3 years in my trading history. I somehow dig out this stock in 2003. I feel immediately excited by it business value after reading public information on its website. Why did I feel so? This is the company which provides routine Pap smear diagnostics for women. 50% of population on this earth is woman and every woman needs this as routine test. There was only one competitor at 2003 and I do not even remember its name now since me though CYTC was a clear leader. Since Cytec’s stock has never dropped sharply and thus it survives in my hand for long long time.

Cervical cancer is one of the major problems in women. Prevention strategies including routine screening and vaccine are the key to the solution of this critical problem. 50% population on earth will sooner or later to have all of these. The developed nations already made these things routine.

CYTC stock price might be a little too high now. A nice correction will be a good chance to load.

Interestingly, all cervical cancer related business has been rewarded substantially because of the huger market and monoplosm. For example:

1. CYTC: the company to screen early sign of cervical cancer pathologically.

2. DIGE: the company to offer fast and convenient diagnostics of certain HPV infection microbiologically. HPV infection is the leading cause of cervical cancer.

3. MERCK (GSK soon) offers vaccine drug to prevent HPV infection for women. Actually Merck’s cervical cancer drug did save Merck from VIOXX problem. Both Merck and GSk bought the drugs from MEDI which is bought by AZN now. AZN will receive substantially rolty from both drugs. That is why I call AZN bottom a few weeks ago.